CUV Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Clinuvel Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price on Oct 15: 7.35 AUD

Market Cap: AU$370.7m

Prices of ASX stocks are not being updated. The latest CUV price on Alpha Spread is from Oct 15, 2026. Financials, forecasts and intrinsic value keep updating.

	Clinuvel Pharmaceuticals Ltd ASX:CUV	AU

Profitability Summary

Clinuvel Pharmaceuticals Ltd's profitability score is 76/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

83%

Strong 3Y Average Gross Margin

95%

Declining Gross Margin

94% > 83%

Exceptional Operating Margin

43%

Strong 3Y Average Operating Margin

51%

Declining Operating Margin

56% > 43%

Exceptional Net Margin

36%

Strong 3Y Average Net Margin

38%

Declining Net Margin

39% > 36%

Exceptional Free Cash Flow Margin

38%

Strong 3Y Average Free Cash Flow Margin

38%

Declining Free Cash Flow Margin

46% > 38%

Positive ROE

13%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

104%

Declining ROIC

122% > 81%

View All

Hide

Collapse

76 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.